MEDICINAL RESEARCH REVIEWS
MEDICINAL RESEARCH REVIEWS(英文缩写 MED RES REV),ISSN 0198-6325,eISSN 1098-1128 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
指标来源：jcr_cas_ifqb
期刊简介
暂无简介。
历年影响因子趋势
| 年份 | 影响因子 | JCR 分区 |
|---|---|---|
| - | Q1 | |
| - | Q1 | |
| - | Q1 | |
| - | Q1 | |
| - | Q1 |
MEDICINAL RESEARCH REVIEWS 最新收录文献
-
Combination of photodynamic therapy and immunomodulation: current status and future trends.
Photodynamic therapy (PDT) has been used for the treatment of nonmalignant and malignant diseases from head to toe. Over the last decade its clinical application has gained increasing acceptance aroun…
-
NAD(+)-dependent DNA ligase: a novel target waiting for the right inhibitor.
DNA ligases (EC.6.5.1.1) are key enzymes that catalyze the formation of phosphodiester bonds at single stranded or double stranded breaks between adjacent 5' phosphoryl and 3' hydroxyl groups of DNA. …
-
4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest.
A comprehensive focus on 4-hydroxynonenal (HNE) as candidate molecule in a variety of pathophysiological conditions occurring in humans is here provided. Despite an active, now well characterized, met…
-
Macrophages: an elusive yet emerging therapeutic target of atherosclerosis.
Macrophages are central to the initiation and progression of atherosclerosis and thus can be very appropriate targets for therapy. Cell adhesion molecules mediating monocytes recruitment to the endoth…
-
Molecular network of cartilage homeostasis and osteoarthritis.
This review article presents the current understanding of the molecular basis of articular cartilaginous homeostasis, and outlines potential areas to focus on within the developing field of therapeuti…
-
Carbonic anhydrase IX: a new druggable target for the design of antitumor agents.
Carbonic anhydrases (CAs, EC 4.2.1.1) are a family of enzymes widespread in all life kingdoms. In mammals, isozyme CA IX is highly overexpressed in many cancer types being present in few normal tissue…
-
Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines.
Despite the evidence that immune effectors can play a significant role in controlling tumor growth under natural conditions or in response to therapeutic manipulation, it is clear that malignant cells…
-
Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy.
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK) involved in the genesis of several human cancers; indeed, ALK was initially identified in constitutively activated and oncogenic fu…
-
Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we?
In view of the large libraries of nucleoside analogues that are now being handled in organic synthesis, the identification of drug biological activity is advisable prior to synthesis and this can be a…
-
Proteasome inhibitors: poisons and remedies.
The proteasome inhibitor bortezomib has been approved as a cytostatic drug for the therapy of multiple myeloma, and is currently being tested in clinical trials for a variety of other malignancies. At…